(Q33810080)

29 July 2017

1 reference

title

Role of HER2 gene overexpression in breast carcinoma (English)

1 reference

29 July 2017

1 reference

Ménard S

1

1 reference

29 July 2017

Tagliabue E

series ordinal

2

1 reference

29 July 2017

Campiglio M

series ordinal

3

1 reference

29 July 2017

Pupa SM

series ordinal

4

1 reference

29 July 2017

1 February 2000

1 reference

Journal of Cellular Physiology

29 July 2017

1 reference

29 July 2017

182

1 reference

29 July 2017

150-162

1 reference

29 July 2017

2

1 reference

Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Vascular anatomy and organ-specific tumor growth as critical factors in the development of metastases and their distribution among organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

The neu oncogene encodes an epidermal growth factor receptor-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Prognostic significance of c-erbB-2 expression in node negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Humanization of an anti-p185HER2 antibody for human cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Targeted tumor killing via an intracellular antibody against erbB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Structure-function relationships for the EGF/TGF-alpha family of mitogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Identification of heregulin, a specific activator of p185erbB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Binding of Neu differentiation factor with the extracellular domain of Her2 and Her3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Effectiveness of an adriamycin immunoconjugate that recognizes the C-erbB-2 product on breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

17 beta-estradiol mimics ligand activity of the c-erbB2 protooncogene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

HER-2/neu oncogene: what does amplification mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

The significance of oncogene amplification in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Bispecific HER2 x CD3 antibodies enhance T-cell cytotoxicity in vitro and localize to HER2-overexpressing xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Bivalence of EGF-like ligands drives the ErbB signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Alternative intracellular routing of ErbB receptors may determine signaling potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Switching signals on or off by receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

The long term prognostic significance of c-erbB-2 in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Phosphoinositide 3-kinases and their FYVE domain-containing effectors as regulators of vacuolar/lysosomal membrane trafficking pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

FISH detection of HER-2/neu oncogene amplification in early onset breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

Engineering high affinity humanized anti-p185HER2/anti-CD3 bispecific F(ab')2 for efficient lysis of p185HER2 overexpressing tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28200002%29182%3A2%3C150%3A%3AAID-JCP3%3E3.0.CO%3B2-E

10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E

21 January 2018

Identifiers

DOI

1 reference

release_zsj4xhzyxzaa3bdhkr6x43xw5i

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zsj4xhzyxzaa3bdhkr6x43xw5i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference